Pharmaceutical Development
Early Clinical Development
Clinical Development
About AAIPharma
Media Press Center

Biomarker Capabilities

Immunocytometry: BD Facscanto II Flowcytometer

Quantifying the immune response in clinical trials to support Proof of Concept Studies using High throughput analysis to obtain multiple results from a single, small volume sample:

 

Immune Response: Cell Analysis

  • T-Lymphocytes/T suppressor cells CD3/CD8/ Helper T cells CD3/CD4
  • B-Lymphocytes CD19 and NK cells CD16/CD56

 

 

Serum/plasma Analysis (CBA Technology)

  • Th1 and Th2 Cytokines (e.g. IL-2, IL-4)
  • Allergy mediators (IL-3, G-CSF)
  • Inflammatory mediators (e.g.IL-8, IL-12p70)

 

AAIPharma Advantage:

  • Quantitative pharmacodynamic data and immune response analysis, expedited results and automated archive raw data back-up
  • Experimental design by multi-parameter measurement of cellular, soluble parameters: 2 lasers, cells up to 6 parameters, serum / plasma (up to 29 parameters)